{'fraction_non_alphanumeric': 0.036637931034482756, 'fraction_numerical': 0.017241379310344827, 'mean_word_length': 5.542253521126761, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
ARI, influenza - infectious complications, experience 2009–2019

The article presents the experience of acute respiratory infections (ARI), influenza in 2009–2019, infectious complications of ARI / flu, objective studies and indications for hospitalization. The conclusion is made about the need for early administration of direct antiviral drugs (SPP). In all cases of detection of viral bacterial pneumonia (PFS), hospitalization is indicated due to the high risk of rapid formation of acute lung injury (ARP), acute respiratory distress syndrome (ARDS), especially in individuals with obesity, diabetes mellitus and late circulation. The main treatment tactic is the use of PPP and antibiotics. Respiratory support for PFS using non-invasive and invasive ventilation (NIVL, IVL) is presented. The choice of antibiotics depends on the severity and type of infectious complication, the risk of strains resistant to methicillin.